184 related articles for article (PubMed ID: 19598026)
1. [Study on specific metabonomic profiling of serum from colorectal cancer patients by gas chromatography-mass spectrometry].
Ma YL; Liu WJ; Peng JY; Zhang P; Chen HQ; Qin HL
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jul; 12(4):386-90. PubMed ID: 19598026
[TBL] [Abstract][Full Text] [Related]
2. Urinary metabonomic study on colorectal cancer.
Qiu Y; Cai G; Su M; Chen T; Liu Y; Xu Y; Ni Y; Zhao A; Cai S; Xu LX; Jia W
J Proteome Res; 2010 Mar; 9(3):1627-34. PubMed ID: 20121166
[TBL] [Abstract][Full Text] [Related]
3. An integrated proteomics and metabolomics approach for defining oncofetal biomarkers in the colorectal cancer.
Ma Y; Zhang P; Wang F; Liu W; Yang J; Qin H
Ann Surg; 2012 Apr; 255(4):720-30. PubMed ID: 22395091
[TBL] [Abstract][Full Text] [Related]
4. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
[TBL] [Abstract][Full Text] [Related]
5. Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS.
Qiu Y; Cai G; Su M; Chen T; Zheng X; Xu Y; Ni Y; Zhao A; Xu LX; Cai S; Jia W
J Proteome Res; 2009 Oct; 8(10):4844-50. PubMed ID: 19678709
[TBL] [Abstract][Full Text] [Related]
6. Kinetic analysis of bile acids in the feces of colorectal cancer patients by gas chromatography-mass spectrometry (GC-MS).
Tadano T; Kanoh M; Kondoh H; Matsumoto M; Mimura K; Kanoh Y; Sakamoto K; Kamano T
Rinsho Byori; 2007 May; 55(5):417-27. PubMed ID: 17593686
[TBL] [Abstract][Full Text] [Related]
7. A pilot study of GC/MS-based serum metabolic profiling of acute rejection in renal transplantation.
Mao YY; Bai JQ; Chen JH; Shou ZF; He Q; Wu JY; Chen Y; Cheng YY
Transpl Immunol; 2008 Apr; 19(1):74-80. PubMed ID: 18346641
[TBL] [Abstract][Full Text] [Related]
8. Distinct urinary metabolic profile of human colorectal cancer.
Cheng Y; Xie G; Chen T; Qiu Y; Zou X; Zheng M; Tan B; Feng B; Dong T; He P; Zhao L; Zhao A; Xu LX; Zhang Y; Jia W
J Proteome Res; 2012 Feb; 11(2):1354-63. PubMed ID: 22148915
[TBL] [Abstract][Full Text] [Related]
9. Tissue metabolomic fingerprinting reveals metabolic disorders associated with human gastric cancer morbidity.
Song H; Wang L; Liu HL; Wu XB; Wang HS; Liu ZH; Li Y; Diao DC; Chen HL; Peng JS
Oncol Rep; 2011 Aug; 26(2):431-8. PubMed ID: 21567103
[TBL] [Abstract][Full Text] [Related]
10. Metabonomic profiling of liver metabolites by gas chromatography-mass spectrometry and its application to characterizing hyperlipidemia.
Gu S; A J; Wang G; Zha W; Yan B; Zhang Y; Ren H; Cao B; Liu L
Biomed Chromatogr; 2010 Mar; 24(3):245-52. PubMed ID: 19606418
[TBL] [Abstract][Full Text] [Related]
11. Global gas chromatography/time-of-flight mass spectrometry (GC/TOFMS)-based metabonomic profiling of lyophilized human feces.
Phua LC; Koh PK; Cheah PY; Ho HK; Chan EC
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Oct; 937():103-13. PubMed ID: 24029555
[TBL] [Abstract][Full Text] [Related]
12. Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry.
Wu H; Xue R; Dong L; Liu T; Deng C; Zeng H; Shen X
Anal Chim Acta; 2009 Aug; 648(1):98-104. PubMed ID: 19616694
[TBL] [Abstract][Full Text] [Related]
13. Serum fatty acid profiling of colorectal cancer by gas chromatography/mass spectrometry.
Kondo Y; Nishiumi S; Shinohara M; Hatano N; Ikeda A; Yoshie T; Kobayashi T; Shiomi Y; Irino Y; Takenawa T; Azuma T; Yoshida M
Biomark Med; 2011 Aug; 5(4):451-60. PubMed ID: 21861667
[TBL] [Abstract][Full Text] [Related]
14. A metabonomic investigation on the biochemical perturbation in liver failure patients caused by hepatitis B virus.
Yu K; Sheng G; Sheng J; Chen Y; Xu W; Liu X; Cao H; Qu H; Cheng Y; Li L
J Proteome Res; 2007 Jul; 6(7):2413-9. PubMed ID: 17539670
[TBL] [Abstract][Full Text] [Related]
15. Metabotyping of human colorectal cancer using two-dimensional gas chromatography mass spectrometry.
Mal M; Koh PK; Cheah PY; Chan EC
Anal Bioanal Chem; 2012 Apr; 403(2):483-93. PubMed ID: 22374317
[TBL] [Abstract][Full Text] [Related]
16. Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry.
Wu H; Xue R; Lu C; Deng C; Liu T; Zeng H; Wang Q; Shen X
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3111-7. PubMed ID: 19716777
[TBL] [Abstract][Full Text] [Related]
17. Gas chromatography/flame ionisation detection mass spectrometry for the detection of endogenous urine metabolites for metabonomic studies and its use as a complementary tool to nuclear magnetic resonance spectroscopy.
Fancy SA; Beckonert O; Darbon G; Yabsley W; Walley R; Baker D; Perkins GL; Pullen FS; Rumpel K
Rapid Commun Mass Spectrom; 2006; 20(15):2271-80. PubMed ID: 16810707
[TBL] [Abstract][Full Text] [Related]
18. Organic solvent extraction and metabonomic profiling of the metabolites in erythrocytes.
Zhang Y; A J; Wang G; Huang Q; Yan B; Zha W; Gu S; Liu L; Ren H; Ren M; Sheng L
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jun; 877(18-19):1751-7. PubMed ID: 19467933
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a gas chromatography/mass spectrometry metabonomic platform for the global profiling of urinary metabolites.
Pasikanti KK; Ho PC; Chan EC
Rapid Commun Mass Spectrom; 2008 Oct; 22(19):2984-92. PubMed ID: 18763274
[TBL] [Abstract][Full Text] [Related]
20. Integrated analysis of serum and liver metabonome in liver transplanted rats by gas chromatography coupled with mass spectrometry.
Wang Y; Tao Y; Lin Y; Liang L; Wu Y; Qu H; Liang T; Cheng Y
Anal Chim Acta; 2009 Feb; 633(1):65-70. PubMed ID: 19110117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
